Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedDocument revision updated from v3.4.1 to v3.4.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; this is a backend version note and does not affect the study information displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer now includes a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' line with revision 'v3.4.0'. The older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' text have been removed.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4. This appears to be a minor administrative update to the study record.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded a Locations section with New Jersey as a study site (New Brunswick, New Jersey).SummaryDifference0.2%

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.